143 related articles for article (PubMed ID: 35032052)
1. Serum soluble programmed cell death 1 levels predict spontaneous functional cure in inactive carriers with chronic hepatitis B.
Hu HH; Jeng WJ; Pan MH; Luo WS; Chang CL; Huang YT; Su CY; Chiang CT; Jen CL; Chien YC; Lu SN; Wang LY; Huang LR; Lee MH; Liu J; Nguyen MH; Chen CJ; Yang HI
Aliment Pharmacol Ther; 2022 Mar; 55(5):558-567. PubMed ID: 35032052
[TBL] [Abstract][Full Text] [Related]
2. Serum soluble programmed death-1 levels predict the spontaneous HBeAg seroclearance in chronic hepatitis B.
Chu YJ; Jeng WJ; Pan MH; Hu HH; Luo WS; Su CY; Chiang CT; Jen CL; Chen CJ; Yang HI
J Gastroenterol; 2022 Jun; 57(6):423-432. PubMed ID: 35459967
[TBL] [Abstract][Full Text] [Related]
3. Role of quantitative hepatitis B surface antigen in predicting inactive carriers and HBsAg seroclearance in HBeAg-negative chronic hepatitis B patients.
Ungtrakul T; Sriprayoon T; Kusuman P; Chunnuan P; Soonklang K; Sornsamdang G; Auewarakul CU; Tanwandee T
Medicine (Baltimore); 2017 Mar; 96(13):e6554. PubMed ID: 28353619
[TBL] [Abstract][Full Text] [Related]
4. Incidence, Factors, and Patient-Level Data for Spontaneous HBsAg Seroclearance: A Cohort Study of 11,264 Patients.
Yeo YH; Tseng TC; Hosaka T; Cunningham C; Fung JYY; Ho HJ; Kwak MS; Trinh HN; Ungtrakul T; Yu ML; Kobayashi M; Le AK; Henry L; Li J; Zhang J; Sriprayoon T; Jeong D; Tanwandee T; Gane E; Cheung RC; Wu CY; Lok AS; Lee HS; Suzuki F; Yuen MF; Kao JH; Yang HI; Nguyen MH
Clin Transl Gastroenterol; 2020 Sep; 11(9):e00196. PubMed ID: 33094953
[TBL] [Abstract][Full Text] [Related]
5. Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study.
Liu J; Yang HI; Lee MH; Lu SN; Jen CL; Wang LY; You SL; Iloeje UH; Chen CJ;
Gastroenterology; 2010 Aug; 139(2):474-82. PubMed ID: 20434450
[TBL] [Abstract][Full Text] [Related]
6. [Observation of PD-1
He J; Yao YQ; Xia RX; Qiu TJ; Long L; Wang Y; Jiang Y
Zhonghua Gan Zang Bing Za Zhi; 2022 Mar; 30(3):316-322. PubMed ID: 35462489
[No Abstract] [Full Text] [Related]
7. A predictive scoring system for the seroclearance of HBsAg in HBeAg-seronegative chronic hepatitis B patients with genotype B or C infection.
Liu J; Lee MH; Batrla-Utermann R; Jen CL; Iloeje UH; Lu SN; Wang LY; You SL; Hsiao CK; Yang HI; Chen CJ
J Hepatol; 2013 May; 58(5):853-60. PubMed ID: 23246508
[TBL] [Abstract][Full Text] [Related]
8. High levels of soluble programmed death-1 are associated with virological response in chronic hepatitis B patients after antiviral treatment.
Tan N; Luo H; Kang Q; Pan J; Cheng R; Xi H; Chen H; Han Y; Yang Y; Xu X
Virus Res; 2022 Feb; 309():198660. PubMed ID: 34929214
[TBL] [Abstract][Full Text] [Related]
9. Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance and seroconversion in hepatitis B e antigen-negative chronic infection patients: A population-based prospective cohort.
Zhu L; Zhai X; Wang Q; Jiang J; Peng H; Song C; Ge Z; Qian J; Zhou M; Zhou Y; Xu J; Liu H; Hang D; Hu Z; Shen H; Zhu F
J Viral Hepat; 2018 Dec; 25(12):1588-1598. PubMed ID: 30112835
[TBL] [Abstract][Full Text] [Related]
10. Level of Hepatitis B (HB) Core Antibody Associates With Seroclearance of HBV DNA and HB Surface Antigen in HB e Antigen-Seronegative Patients.
Hu HH; Liu J; Chang CL; Jen CL; Lee MH; Lu SN; Wang LY; Quan Y; Xia NS; Chen CJ; Chen PJ; Yang HI
Clin Gastroenterol Hepatol; 2019 Jan; 17(1):172-181.e1. PubMed ID: 29753083
[TBL] [Abstract][Full Text] [Related]
11. Reduction of hepatitis B surface antigen levels and hepatitis B surface antigen seroclearance in chronic hepatitis B patients receiving 10 years of nucleoside analogue therapy.
Seto WK; Wong DK; Fung J; Huang FY; Lai CL; Yuen MF
Hepatology; 2013 Sep; 58(3):923-31. PubMed ID: 23468172
[TBL] [Abstract][Full Text] [Related]
12. Predictors of HBsAg seroclearance in HBeAg-negative chronic hepatitis B patients.
Kwak MS; Cho EJ; Jang ES; Lee JH; Yu SJ; Kim YJ; Yoon JH; Lee HS
Digestion; 2011; 84 Suppl 1():23-8. PubMed ID: 22156482
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B surface antigen levels after hepatitis B e-antigen seroclearance: a longitudinal follow-up study.
Fung J; Seto WK; Wong DK; Lai CL; Yuen MF
Liver Int; 2015 Mar; 35(3):854-9. PubMed ID: 24840542
[TBL] [Abstract][Full Text] [Related]
14. HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability.
Kim GA; Lim YS; An J; Lee D; Shim JH; Kim KM; Lee HC; Chung YH; Lee YS; Suh DJ
Gut; 2014 Aug; 63(8):1325-32. PubMed ID: 24162593
[TBL] [Abstract][Full Text] [Related]
15. Distinct seromarkers predict different milestones of chronic hepatitis B progression.
Liu J; Yang HI; Lee MH; Batrla-Utermann R; Jen CL; Lu SN; Wang LY; You SL; Hsiao CK; Chen CJ;
Hepatology; 2014 Jul; 60(1):77-86. PubMed ID: 24700432
[TBL] [Abstract][Full Text] [Related]
16. Low Hepatitis B Core-Related Antigen Levels Correlate Higher Spontaneous Seroclearance of Hepatitis B Surface Antigen in Chronic Hepatitis B Patients With High Hepatitis B Surface Antigen Levels.
Tseng TC; Chiang C; Liu CJ; Hong CM; Su TH; Yang HC; Yang WT; Liu CH; Chen PJ; Kao JH
Gastroenterology; 2023 Apr; 164(4):669-679.e6. PubMed ID: 36642151
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with spontaneous HBsAg clearance in chronic hepatitis B patients followed at a university hospital.
Ferreira SC; Chachá SG; Souza FF; Teixeira AC; Santana RC; Villanova MG; Zucoloto S; Ramalho LN; Perdoná GS; Passos AD; Martinelli AL
Ann Hepatol; 2014; 13(6):762-70. PubMed ID: 25332262
[TBL] [Abstract][Full Text] [Related]
18. Metabolic Dysfunction-Associated Steatotic Liver Disease Facilitates Hepatitis B Surface Antigen Seroclearance and Seroconversion.
Huang SC; Su TH; Tseng TC; Chen CL; Hsu SJ; Liu CH; Liao SH; Hong CM; Lan TY; Yang HC; Liu CJ; Chen PJ; Kao JH
Clin Gastroenterol Hepatol; 2024 Mar; 22(3):581-590.e6. PubMed ID: 37871842
[TBL] [Abstract][Full Text] [Related]
19. Plasma interferon-gamma-inducible-protein 10 level as a predictive factor of spontaneous hepatitis B surface antigen seroclearance in chronic hepatitis B patients.
Kan K; Wong DK; Hui RW; Seto WK; Yuen MF; Mak LY
J Gastroenterol Hepatol; 2024 Jan; 39(1):202-209. PubMed ID: 37794699
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of intrahepatic hepatitis B virus covalently closed circular DNA and total DNA in patients with acute hepatitis B and patients with chronic hepatitis B receiving anti‑viral treatment.
Ruan P; Zhou B; Dai X; Sun Z; Guo X; Huang J; Gong Z
Mol Med Rep; 2014 Apr; 9(4):1135-41. PubMed ID: 24566465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]